Q on the market for 9 months now...
Belviq on the market for 4 weeks....
Keep hyping that magic ratio fixed dose combo though..... it only makes Belviq look better......
How many Q patients are able to titrate up to tolerate high dose that produces peak weight loss?
How about losing 1.9 billion dollars in value since Q started in the market. You will need many more scripts to pay for this loss not lets not forget the several hundred million dollars you will have to dish out to pay for the FDA required studies. Arena will increase in value and VVUS will continue to get further into debt.
How do you like those manzanas y naranjas?
Sentiment: Strong Buy
BTW - you've been wrong about most everything you've ever posted about ARNA and VVUS, and I don't mean the science, which is also not relevant to what real revenues will be gleaned. Just because you're a doc does not make you an expert about stock valuations.
VVUS is irrelevant to ARNA's success, which will be modest and valued at around $4.00. VVUS won't do well either, but better than ARNA because their drug if more effective and REMS will disappear as it was designed by the FDA by end of this year.
I hope you lose all the weight you anticipate, and many more will as well - it just won't make Belviq a blockbuster and ARNA's real value with a net of 12 million for the year will bring investors to their knees. But I hope it serves your life well, and I mean that.